What is the 13F Pro Quality Score for CNC?

13F Pro ranks CENTENE CORP (CNC) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View CNC's current score at https://13fpro.ai/research/CNC (free sign-up required for the full ranking).

Which hedge funds own the most CNC stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of CNC include BlackRock,, AQR CAPITAL MANAGEMENT, VANGUARD CAPITAL MANAGEMENT. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/CNC as soon as new 13F filings post.

Where does 13F Pro source CNC data?

All CENTENE CORP fundamentals and ownership data come directly from SEC EDGAR. CENTENE CORP files with the SEC under CIK 1071739. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is CNC in?

CENTENE CORP (CNC) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is CNC research updated on 13F Pro?

CNC's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

CENTENE CORP(CNC)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSE

Institutional-grade research for retail investors

SEC EDGAR: CIK 1071739 CNC stock profile & AI dashboard →

13F Pro Quality Score

52.7/100

Rank #1,328 of 2,879 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

67.5/100

Profitability

25.7/100

Balance Sheet

23.7/100

Earnings Quality

30.0/100

Free Cash Flow

49.9/100

Institutional Flow

44.5/100

Revenue Scale

99.3/100

Dilution Risk

88.2/100

CNC Stock Analysis & AI Quality Score

AI stock analysis and institutional research for CENTENE CORP (CNC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CNC at 52.7/100 on a 32-signal composite quality model, placing it at rank #1,328 of 2,879 stocks — the top half of the AI-ranked universe. CNC scores in the top quartile across revenue scale (99.3). Areas of concern include balance sheet strength (23.7) and profitability (25.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), CENTENE CORP reports quarterly revenue of $49.9B, net income of $1.5B, free cash flow of $4.2B. Top institutional holders of CNC by reported 13-F value include BlackRock,, AQR CAPITAL MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. CNC trades on the NYSE exchange and files with the SEC under CIK 1071739. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CNC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CENTENE CORP directly from SEC EDGAR. CENTENE CORP's 13F Pro composite quality score has ranged between 8 and 64 since 2021, currently 52.7 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.

✦

Fun facts about CENTENE CORP

Quirks, history, and lore behind CNC — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. managed care company · large-cap · listed on NYSE · headquartered in Missouri.
2
The Numbers
Annual revenue north of $140 billion, making it one of the largest health insurers in America — yet its margins are famously razor-thin.
3
The History
Founded in 1984, it grew by doing what bigger rivals ignored: specializing in government-sponsored health programs like Medicaid and Medicare.
4
The Secret
Its core customers aren't employers or individuals — they're state governments, contracting out the messy business of covering low-income and vulnerable populations.
5
The Lore
It has quietly become the largest Medicaid managed care organization in the U.S., operating in dozens of states and serving tens of millions of members most people have never heard it cover.
6
The Giveaway
If you're on Medicaid or a government health plan and have no idea who's actually administering it, there's a decent chance it's this St. Louis giant — ticker CNC.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$49.9B

Net Income

Q1 2026

$1.5B

Free Cash Flow

Q1 2026

$4.2B

D/E Ratio

Q1 2026

0.76

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+19.4% YoY

$194.78BFY 2025

FY22 $144.55BFY23 $154.00BFY24 $163.07BFY25 $194.78B

Net Income

-301.9% YoY

$-6.67BFY 2025

FY22 $1.20BFY23 $2.70BFY24 $3.31BFY25 $-6.67B

Operating Income

-340.1% YoY

$-7.62BFY 2025

FY22 $1.32BFY23 $2.93BFY24 $3.17BFY25 $-7.62B

EPS (Diluted)

-314.4% YoY

$-13.53FY 2025

FY22 $2.07FY23 $4.95FY24 $6.31FY25 $-13.53

Total Assets

-6.9% YoY

$76.75BFY 2025

FY22 $76.87BFY23 $84.64BFY24 $82.44BFY25 $76.75B

Total Debt

-6.4% YoY

$17.54BFY 2025

FY22 $18.26BFY23 $18.08BFY24 $18.75BFY25 $17.54B

Op. Cash Flow

+3203.9% YoY

$5.09BFY 2025

FY22 $6.26BFY23 $8.05BFY24 $154.0MFY25 $5.09B

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019
Revenue	$194.78B +19.4%	$163.07B +5.9%	$154.00B +6.5%	$144.55B +30.1%	$111.11B +48.9%	$74.64B
Net Income	$-6.67B -301.9%	$3.31B +22.3%	$2.70B +124.8%	$1.20B -33.5%	$1.81B +36.9%	$1.32B
Operating Income	$-7.62B -340.1%	$3.17B +8.4%	$2.93B +122.3%	$1.32B -57.2%	$3.08B +73.0%	$1.78B
EPS (Diluted)	$-13.53 -314.4%	$6.31 +27.5%	$4.95 +139.1%	$2.07 -33.7%	$3.12 -0.6%	$3.14
Total Assets	$76.75B -6.9%	$82.44B -2.6%	$84.64B +10.1%	$76.87B +11.9%	$68.72B +67.6%	$40.99B
Total Debt	$17.54B -6.4%	$18.75B +3.7%	$18.08B -1.0%	$18.26B +7.6%	$16.98B +21.7%	$13.95B
Operating Cash Flow	$5.09B +3203.9%	$154.0M -98.1%	$8.05B +28.6%	$6.26B +13.8%	$5.50B +271.1%	$1.48B

Get alerted when CNC's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for CENTENE CORP including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of CNC

BlackRock, Inc.
$1.3B39,822,399 sh
AQR CAPITAL MANAGEMENT LLC
$1.1B33,613,787 sh
VANGUARD CAPITAL MANAGEMENT LLC
$1.0B31,234,065 sh
STATE STREET CORP
$708.7M21,646,128 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$708.2M21,629,537 sh
HARRIS ASSOCIATES L P
$461.5M14,094,531 sh
GEODE CAPITAL MANAGEMENT, LLC
$424.8M12,987,512 sh
Invesco Ltd.
$347.6M10,616,171 sh
AMERIPRISE FINANCIAL INC
$331.6M10,128,198 sh
MORGAN STANLEY
$323.5M9,880,236 sh

Fund	Value	Shares
BlackRock, Inc.	$1.3B	39,822,399
AQR CAPITAL MANAGEMENT LLC	$1.1B	33,613,787
VANGUARD CAPITAL MANAGEMENT LLC	$1.0B	31,234,065
STATE STREET CORP	$708.7M	21,646,128
VANGUARD PORTFOLIO MANAGEMENT LLC	$708.2M	21,629,537
HARRIS ASSOCIATES L P	$461.5M	14,094,531
GEODE CAPITAL MANAGEMENT, LLC	$424.8M	12,987,512
Invesco Ltd.	$347.6M	10,616,171
AMERIPRISE FINANCIAL INC	$331.6M	10,128,198
MORGAN STANLEY	$323.5M	9,880,236

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put CNC on your watchlist

Track score changes the day CENTENE CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is CNC a good stock to buy?

13F Pro's AI-powered analysis of CENTENE CORP (CNC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CNC are available on the CNC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own CNC?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CNC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CENTENE CORP's investment landscape.